| For: | Kong XQ, Huang YX, Li JL, Zhang XQ, Peng QQ, Tang LR, Wu JX. Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer. World J Gastrointest Oncol 2018; 10(10): 351-359 [PMID: 30364886 DOI: 10.4251/wjgo.v10.i10.351] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v10/i10/351.htm |
| Number | Citing Articles |
| 1 |
Arun Kanakkanthara, John H. Miller. βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(2) doi: 10.1016/j.bbcan.2021.188607
|
| 2 |
Cheng-Hong Yang, Wen-Ching Chen, Jin-Bor Chen, Hsiu-Chen Huang, Li-Yeh Chuang. Overall mortality risk analysis for rectal cancer using deep learning-based fuzzy systems. Computers in Biology and Medicine 2023; 157 doi: 10.1016/j.compbiomed.2023.106706
|
| 3 |
Hui Ge, Hui Tang, Tingting You, Chunmei Bai, Zhao Sun, Qin Han, Robert Chunhua Zhao. TUBB3 (βIII-tubulin) drives gastric cancer progression and poor prognosis by regulating cell cycle and invadopodia formation. Cancer Biomarkers 2025; 42(10) doi: 10.1177/18758592251390145
|
| 4 |
George Sharbeen, John Kokkinos, Grace Schulstad, Elvis Pandzic, Janet Youkhana, Zerong Ma, Rosa Mistica C. Ignacio, Aparna S. Raina, Shannon Chiang, Cyrille Boyer, Koroush S. Haghighi, Matthew Gunawarman, David Goldstein, Val Gebski, Marina Pajic, Meagan E. Davis, Oliver S. M. Arkell, Chantal Kopecky, Estrella Gonzales-Aloy, Alexander Ishak, Mert Erkan, Jennifer P. Morton, Maria Kavallaris, Peter W. Gunning, Edna C. Hardeman, Amber Johns, Anthony J. Gill, Renee M. Whan, Amanda Mawson, Omali Pitiyarachchi, Joshua A. McCarroll, Phoebe A. Phillips. βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer. Cell Death & Disease 2026; 17(1) doi: 10.1038/s41419-026-08657-6
|
| 5 |
Juan Carlos Restrepo, Diana Dueñas, Zuray Corredor, Yamil Liscano. Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment. Cancers 2023; 15(13) doi: 10.3390/cancers15133474
|